ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+15.27%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$368M
AUM Growth
+$368M
(+33%)
Cap. Flow
+$60.7M
Cap. Flow
% of AUM
16.49%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
80
New
27
Increased
20
Reduced
13
Closed
19
Top Buys
| 1 |
Sanofi
SNY
|
$13.5M |
| 2 |
CVS Health
CVS
|
$12.6M |
| 3 |
OrthoPediatrics
KIDS
|
$9.9M |
| 4 |
AdaptHealth
AHCO
|
$9.16M |
| 5 |
AstraZeneca
AZN
|
$9.01M |
Top Sells
| 1 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$39.1M |
| 2 |
Aclaris Therapeutics
ACRS
|
$16.9M |
| 3 |
SI-BONE Inc
SIBN
|
$7.62M |
| 4 |
Smith & Nephew
SNN
|
$7.55M |
| 5 |
Owens & Minor
OMI
|
$5.28M |
Sector Composition
| 1 | Healthcare | 89.39% |
| 2 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
OrthoPediatrics
KIDS
$536M
| $19.3M | 5.04% | 396,162 +203,154 | +105% | +$9.9M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $14.8M | 3.85% | 233,898 -10,168 | -4% | -$642K |
|
|
3
AdaptHealth
AHCO
$1.28B
| $14.7M | 3.83% | 399,730 +249,316 | +166% | +$9.16M |
|
|
4
Sanofi
SNY
$121B
| $13.5M | 3.51% | +272,218 | New | +$13.5M |
|
5
Becton Dickinson
BDX
$55.3B
| $13.2M | 3.45% | 54,355 -14,909 | -22% | -$3.63M |
|
|
6
CVS Health
CVS
$92.8B
| $12.6M | 3.28% | +167,362 | New | +$12.6M |
|
|
7
AstraZeneca
AZN
$248B
| $11.8M | 3.09% | 238,099 +181,208 | +319% | +$9.01M |
|
8
Labcorp
LH
$23.1B
| $11.5M | 3.01% | 45,224 +25,390 | +128% | +$6.47M |
|
|
9
Aclaris Therapeutics
ACRS
$209M
| $11.5M | 2.99% | 455,385 -671,290 | -60% | -$16.9M |
|
10
Elevance Health
ELV
$71.8B
| $11.4M | 2.98% | 31,798 +9,164 | +40% | +$3.29M |
|
11
Encompass Health
EHC
$12.3B
| $11M | 2.86% | 133,801 +60,697 | +83% | +$4.97M |
|
12
Iovance Biotherapeutics
IOVA
$807M
| $9.84M | 2.56% | 310,649 +256,428 | +473% | +$8.12M |
|
13
AbbVie
ABBV
$372B
| $9.52M | 2.48% | 87,982 +3,438 | +4% | +$372K |
|
|
MTEM
14
DELISTED
Molecular Templates, Inc.
MTEM
| $8.95M | 2.33% | 709,360 +28,117 | +4% | +$355K |
|
|
IVC
15
DELISTED
Invacare Corporation
IVC
| $8.88M | 2.32% | +1,107,112 | New | +$8.88M |
|
16
McKesson
MCK
$85.4B
| $8.61M | 2.24% | +44,132 | New | +$8.61M |
|
17
Bio-Rad Laboratories Class A
BIO
$8.06B
| $8.44M | 2.2% | +14,784 | New | +$8.44M |
|
18
Elutia
ELUT
$96.7M
| $8.07M | 2.1% | 583,600 +175,387 | +43% | +$2.42M |
|
|
SYNH
19
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $8M | 2.09% | 105,521 +3,568 | +3% | +$271K |
|
|
PHAS
20
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $7.49M | 1.95% | +2,163,518 | New | +$7.49M |
|
21
Cencora
COR
$56.5B
| $7.41M | 1.93% | 62,722 -15,617 | -20% | -$1.84M |
|
22
Ocular Therapeutix
OCUL
$2.12B
| $7.2M | 1.88% | 438,933 +148,468 | +51% | +$2.44M |
|
23
Avantor
AVTR
$9.18B
| $6.97M | 1.82% | 241,016 +46,239 | +24% | +$1.34M |
|
24
Boston Scientific
BSX
$156B
| $6.13M | 1.6% | +158,702 | New | +$6.13M |
|
25
DarioHealth
DRIO
$22.8M
| $6.12M | 1.6% | +317,876 | New | +$6.12M |
|